Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,011,868
+$1,701,117 QoQ
Shares Held
5,846
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,472
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. LLY ranks #1 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,261 | $411,994 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,011,868 | 5,846 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,310,751 | 5,774 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,012,835 | 5,595 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,415,481 | 5,787 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $4,228,170 | 5,424 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $4,757,241 | 5,760 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $4,548,624 | 5,892 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,297,921 | 5,980 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,193,259 | 5,736 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,348,796 | 5,590 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,648,205 | 4,543 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,403,119 | 4,474 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,096,340 | 4,470 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,589,004 | 4,627 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,698,595 | 4,643 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,751,263 | 5,416 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,705,774 | 5,261 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,579,616 | 5,516 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,403,197 | 5,080 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $835,707 | 3,617 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $827,419 | 3,605 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $665,079 | 3,560 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $530,832 | 3,144 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $435,178 | 2,940 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $485,808 | 2,959 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $355,123 | 2,560 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||